AI-generated summary
The authors pooled ten clinical studies, including 473 participants, of low-level light therapy used alone for dry eye disease. They report significant improvements in symptom scores and tear measures, with no adverse events reported, though the sensitivity analysis showed no significant effect on tear meniscus height.
- Participants
- 473
- Studies included
- 10
- Who or what was studied
- Patients with dry eye disease and meibomian gland dysfunction
- Wavelengths
- 625, 640, 810, 850 nm
- Limits stated in the abstract
- The abstract does not state the certainty of the evidence, and the tear meniscus height result was not significant in the sensitivity analysis restricted to randomized controlled trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 625-640 nm, 810-850 nm
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Low-level laser therapy, Systematic review, Meta-analysis, Dry eye. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.